1. SAT0155 Adalimumab in combination with non-methotrexate conventional synthetic disease modifying rheumatic drugs in a clinical trial setting. (15th June 2017) Authors: Keystone, EC; Suboticki, J; Griffith, J; Zhang, Y; Kremer, JM Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 828 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis. (2nd September 2020) Authors: Emery, P; Suh, C-H; Weinblatt, ME; Smolen, JS; Keystone, EC; Genovese, M; Vencovsky, J; Kay, J; Hong, E; Baek, Y; Ghil, J Journal: Scandinavian journal of rheumatology Issue: Volume 49:Number 5(2020) Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P092 Microarray pathway analysis comparing baricitinib and adalimumab in moderate to severe rheumatoid arthritis from a phase 3 study. (21st February 2018) Authors: Emery, P; Taylor, PC; Weinblatt, ME; Tanaka, Y; Keystone, EC; Dow, ER; Higgs, R; Macias, WL; Rocha, G; Rooney, TP; Schlichting, DE; Zuckerman, SH; McInnes, IB; Holzkaemper, T Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 1 Page Start: A52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis. (2nd September 2020) Authors: Emery, P; Suh, C-H; Weinblatt, ME; Smolen, JS; Keystone, EC; Genovese, M; Vencovsky, J; Kay, J; Hong, E; Baek, Y; Ghil, J Journal: Scandinavian journal of rheumatology Issue: Volume 49:Number 5(2020) Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗